Screener
Ionis Pharmaceuticals IONS Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Ionis Pharmaceuticals’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 5:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000874015-26-000251
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Property, plant and equipment, net | 155,131 | 123,048 |
| Right-of-use assets | 231,560 | 238,549 |
| Deposits and other assets | 116,536 | 171,604 |
| Total assets | $$2,994,501 | 3,523,836 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $$47,704 | 28,082 |
| Accrued compensation | 50,293 | 116,236 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Ionis Pharmaceuticals's total assets?
- Ionis Pharmaceuticals (IONS) reported total assets of $2.99B in Q2 2026.
- How has Ionis Pharmaceuticals's total assets changed year-over-year?
- Ionis Pharmaceuticals's total assets increased by 0.3% year-over-year, from $2.99B to $2.99B.
- What is the long-term trend for Ionis Pharmaceuticals's total assets?
- Over 5 years (2020 to 2025), Ionis Pharmaceuticals's total assets has grown at a 8.1% compound annual growth rate (CAGR), from $2.39B to $3.52B.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Ionis Pharmaceuticals's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude